Your browser doesn't support javascript.
SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.
Camb Q Healthc Ethics ; 30(1): 59-68, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1047895
ABSTRACT
The world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to "normal." Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern is the potential danger to the health of human test subjects and, eventually, many vaccine recipients. This is further complicated by economic and political pressures to reduce government oversight on rushed vaccine testing and production, nationalistic distribution goals, and failure to plan for the widespread immunization needed to produce global herd immunity. As this paper asserts, the public must be better informed to assess promises about the novel vaccines being produced and to tolerate delays and uncertainty.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / Drug Development / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Camb Q Healthc Ethics Journal subject: Ethics Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / Drug Development / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Camb Q Healthc Ethics Journal subject: Ethics Year: 2021 Document Type: Article